Dimerix to outline capital raising
Dimerix (ASX:DXB) has been granted a trading halt by the ASX.
Company
Dimerix Ltd
ASX:DXB
Dimerix Ltd is a clinical-stage biopharmaceutical company, with a portfolio of drug candidates for inflammatory diseases, including kidney and respiratory diseases. The company's lead candidate is in Phase 3 clinical trials for a rare type of kidney disease.
22 stories · page 2 of 2